Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_leftBack to RenovoRx.com
RenovoRX, Inc. IR Overview
  • Investors
  • Company Info
    • Company Profile
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Press Releases
    • Clinical News
    • IR Calendar Events
    • Email Alerts
  • Financial Info
    • Financial Information Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • SEC Filings Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Stock Information
  • chevron_leftBack to RenovoRx.com

Press Releases

News & Events

  • Press Releases
  • Clinical News
  • IR Calendar Events
  • Email Alerts
Jan 29, 2024 8:30 am EST
RenovoRx Closes $6.1 Million Private Placement
Dec 21, 2023 8:30 am EST
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
Dec 19, 2023 8:30 am EST
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Dec 13, 2023 8:31 am EST
RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
Nov 16, 2023 8:35 am EST
RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
Nov 14, 2023 8:30 am EST
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
Oct 2, 2023 8:30 am EDT
RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
Aug 17, 2023 8:30 am EDT
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
Jul 31, 2023 8:30 am EDT
RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
Jul 20, 2023 8:00 am EDT
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Page 18
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
©2026 RenovoRX, Inc. All Rights Reserved.
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.